Back

Why carvedilol improve the long-term survival in heart failure patients? A difference in barorecepter-mediated blood pressure regulation between beta and beta/alpha blockers-

28 August 2016 (10:12 - 10:19)
Organised by:
Congress Presentation Part of: Drug treatment of hypertension Autonomic nervous system and humoral regulations ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Hiromi Yamamoto

Kinki University, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
Cardiovascular treatment among hypertensive patients in 12 African countries : EIGHT study
Doctor M. Antignac (Paris, FR)
Abstract Slides
Presentation thumbnail
Results of the ESCAPE trial: an italian, multi-centre, phase IV, randomized, controlled, open-label trial on the effects of canrenone in hypertensive patients
Professor G. Derosa (Pavia, IT)
Abstract
Presentation thumbnail
Rubus occidentalis extract significantly lowered systolic blood pressure in subjects with prehypertension: randomized, double-blinded, placebo controlled clinical trial
Associate Professor S. Hong (Seoul, KR)
Presentation thumbnail
Simplification of antihypertensive therapy in resistant arterial hypertension
Associate Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides
Presentation thumbnail
Improving blood pressure control beyond the guidelines
Assistant Professor A. Farcas (Cluj Napoca, RO)
Abstract Slides

Access the full session

Session thumbnail
Drug treatment of hypertension

The Event

Event poster

ESC Congress 2016

28 August 2016 10:12 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources